Pay in 4 interest-free payments of $7.25 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
DRD1 Rs4532 Polymorphism: A Potential Pharmacogenomic Marker for Treatment Response to Antipsychotic Drugs. Schizophrenia Research, vol
Other common side effects reported in 5% or more of people in clinical trials include: Digestive system Indigestion (dyspepsia) Abdominal pain or upper abdominal pain Gastroenteritis (stomach bug) Increased lipase levels (a pancreatic enzyme, detected on blood tests) General Headache Fatigue (feeling tired) Dizziness Fever Other Injection site reactions such as redness, irritation, or bruising Low blood sugar (hypoglycemia), particularly if you also take insulin or a sulfonylurea Contact your doctor if any side effects are severe, persistent, or affecting your daily life
In clinical trial protocols, the drug is initiated at a low dose and titrated gradually upwards to minimise gastrointestinal side effects
21 (21), 8359 (2020) O.S
Interestingly, FOXO4-DRI did not affect cell viability in PDL3 group (Supplementary Figures 1, 2)
US$ 29.31
US$ 27.37
US$ 27.25
US$ 23.23
.png)
US$ 24.87
